Prilosec OTC Shortages Due To Inaccurate Projections, Global Supply Chain
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble is building up enough Prilosec OTC inventory to allow retailers to re-launch the product
You may also be interested in...
Prilosec OTC, Nexium Launches Fed “Shark Fin” Monopoly Plan, Suit Claims
Elements of the Prilosec OTC launch, ranging from the drug's 14-day term of use to supply shortages during its time on the market, were part of a plan by AstraZeneca to interfere with generic competition for its prescription proton pump inhibitors, retailers allege in a lawsuit against the U.K. drug maker
Gillette Drives P&G Health Care Sales Growth, Boosts Beauty Segment
The addition of Gillette Oral Care to Procter & Gamble's portfolio has driven P&G Health Care sales up 21% to $2.4 bil. for the third quarter ended March 31, the firm reported during a May 3 analyst call
Prilosec OTC Demand Taxing P&G Supply Chain Efficiency
Procter & Gamble is addressing shortfalls in its supply chain in order to meet higher than expected customer demand for Prilosec OTC